Loading...

Please Note

  • You must enable pop-up and redirect settings in your browser to apply for jobs Learn How
  • Salary Range is an estimated salary suggested for this role based on publically available data. It was not provided by the employer for this specific position

Visual Inspector, Hikari Site/光工場バイアル、注射剤の目視検査員 (契約社員)

Japan Takeda Pharmaceuticals ¥2,500,000–¥3,500,000/year*
Job Description

The Visual Inspector at Hikari Site is responsible for the manual inspection of vials and injectable products to ensure quality and compliance with safety standards. Candidates should have keen attention to detail, good eyesight, and the ability to work in a fast-paced environment. Prior experience in a similar role or in a pharmaceutical setting is preferred. The candidate must be able to follow strict protocols and maintain accurate records of inspections.

Company Info

Takeda Pharmaceuticals is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. With a commitment to bringing better health and a brighter future to people worldwide, Takeda focuses on innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases. The company is dedicated to improving patient outcomes through sustainable healthcare solutions and operates in over 80 countries, employing a diverse workforce committed to integrity and excellence.

Destination Guide

Japan, an island nation in East Asia, offers a unique blend of traditional culture and modern lifestyle. Known for its advanced technology, Japan provides numerous job opportunities, especially in sectors like technology, healthcare, and manufacturing. The lifestyle is a mix of bustling city life and serene countryside, with a strong emphasis on respect and community. Japan has a well-structured visa system for skilled workers, and relocation support is often provided by employers. The country is renowned for its efficient public transport, safety, and high standard of living, making it an attractive destination for expatriates.

Loading...